ANZ
ANZ out with a big simplification drive. 3500 people will leave the business (more if you include contractors). That’s ~8% of the company, on the below measures.

There’s a lot of ways to measure “size” for a bank. We won’t use market cap, because that’s a bit distorted, at the moment, by CBA being valued like a secular growth tech stock. But, if we take the ratio of loans, (76/90=~84%) and compare to staff (43/51=~84%) they don’t seem wildly off, and will now be more favourable to ANZ, assuming they don’t “lose loans” off the back of reducing headcount.

You could make the argument that ANZ is still “less productive”, no matter how you cut it, by looking at the efficiency ratio. Again, assuming no negative consequence of letting just under 10% of the workforce go, you’d imagine ANZ might be a bit more comparable to CBA.

Tech/AI/Earnings
Yesterday, we wrote a little about WTC and XRO in terms of M&A. It is worth noting, that over the last 4 years, whilst tech/secular growth names like CAR and REA have done a great job growing earnings, we do find that PE expansion is still much of the total return (and half, in CARs and REAs case). Half.
They trade on fairly elevated multiples, 34, 45x forward, SEEK (SEK) on the far right below is on 45x, and has actually had a fairly choppy path to earnings. They appear to be on the mend, and the recent result was good in that the price lever was pulled, even as volumes (local ads) were fairly muted.

The earnings growth potential isn’t really in doubt with the above names. It’s just the valuation argument, as it has been for all these sectors we’ve looked at, using this lens, on this blog (last week was Consumer stocks). Do you want to pay ~30-50x forward earnings. Are there less exciting, more reasonably priced names, that should still do the job for you? Or is the only path forward to grit one’s teeth and “pony up”, in the expectation that they’ll grow into their earnings.
Perhaps real estate agents and homeowners don’t mind the REA tax. Or that Domain will remain a distant second. Maybe SEK can continue to pull the price lever, and not lose share to another willing to tolerate lower margins. That’s the rub, that’s the source of market disagreement. Those in the names say yes, and those out of it say “it’s in the price, and then some”.
Lithium
The below is a good reminder of the boon and bane of pureplays. If you liked lithium, when CATL cut production, you could a) play it via something like a RIO, where, sure, you get a bit of exposure and uplift, but, it is part of a diversified or b) a pure play, like PLS or IGO, and get max leverage to a positive bit of news in a beaten up sector.

That all sounds great, on the assumption that you are quick in, quick out (realise the gains) because if the narrative changes, for whatever reason (in the above, CATL are restarting production), then you get max leverage/exposure to the downside, which is what PLS and IGO are finding today.
Our preference, boring though it is, most of the time, is to stick with a diversified. We have had periodic exceptions (for example, WHC managed to double production without issuing a single share, which we thought was exceptional) but in general, stick to the large cap diversifieds.
Plus, in the case of BHP and RIO, you can argue that Aluminium and Copper look good, even as lithium looks cheap, so, whilst diversified, those other bits are still quite attractive, we think.
Important Information: This document has been prepared by Aequitas Investment Partners Pty Ltd ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of AIP FS Pty Ltd ABN 49 680 982 478 (Australian Financial Services Licensee no. 700016) and is for distribution within Australia to wholesale clients only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Aequitas is not authorised to provide tax (financial) advice and is not a registered tax agent. Investors should seek their own tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law. We recommend that you consult a registered tax agent or a tax specialist to confirm your taxation position.